These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 8830310

  • 1. Acetylcholinesterase, a senile plaque component, affects the fibrillogenesis of amyloid-beta-peptides.
    Alvarez A, Bronfman F, Pérez CA, Vicente M, Garrido J, Inestrosa NC.
    Neurosci Lett; 1995 Dec 01; 201(1):49-52. PubMed ID: 8830310
    [Abstract] [Full Text] [Related]

  • 2. Alzheimer's beta-amyloid peptide is conformationally modified by apolipoprotein E in vitro.
    Soto C, Golabek A, Wisniewski T, Castaño EM.
    Neuroreport; 1996 Feb 29; 7(3):721-5. PubMed ID: 8733730
    [Abstract] [Full Text] [Related]

  • 3. Acetylcholinesterase is a senile plaque component that promotes assembly of amyloid beta-peptide into Alzheimer's filaments.
    Inestrosa NC, Alvarez A, Calderón F.
    Mol Psychiatry; 1996 Nov 29; 1(5):359-61. PubMed ID: 9154226
    [No Abstract] [Full Text] [Related]

  • 4. Amyloid fibril formation by a synthetic peptide from a region of human acetylcholinesterase that is homologous to the Alzheimer's amyloid-beta peptide.
    Cottingham MG, Hollinshead MS, Vaux DJ.
    Biochemistry; 2002 Nov 19; 41(46):13539-47. PubMed ID: 12427014
    [Abstract] [Full Text] [Related]

  • 5. Fibrillogenesis in Alzheimer's disease of amyloid beta peptides and apolipoprotein E.
    Castano EM, Prelli F, Wisniewski T, Golabek A, Kumar RA, Soto C, Frangione B.
    Biochem J; 1995 Mar 01; 306 ( Pt 2)(Pt 2):599-604. PubMed ID: 7534068
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Two conformational states of amyloid beta-peptide: implications for the pathogenesis of Alzheimer's disease.
    Soto C, Frangione B.
    Neurosci Lett; 1995 Feb 17; 186(2-3):115-8. PubMed ID: 7777177
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Acetylcholinesterase (AChE)--amyloid-beta-peptide complexes in Alzheimer's disease. the Wnt signaling pathway.
    Inestrosa NC, Urra S, Colombres M.
    Curr Alzheimer Res; 2004 Nov 17; 1(4):249-54. PubMed ID: 15975054
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Neurotoxicity of acetylcholinesterase amyloid beta-peptide aggregates is dependent on the type of Abeta peptide and the AChE concentration present in the complexes.
    Muñoz FJ, Inestrosa NC.
    FEBS Lett; 1999 May 07; 450(3):205-9. PubMed ID: 10359075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Occurrence of acetylcholinesterase activity closely associated with amyloid beta/A4 protein is not correlated with acetylcholinesterase-positive fiber density in amygdala of Alzheimer's disease.
    Nakamura S, Takemura M, Suenaga T, Akiguchi I, Kimura J, Yasuhara O, Kimura T, Kitaguchi N.
    Acta Neuropathol; 1992 May 07; 84(4):425-32. PubMed ID: 1441923
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.